LIVS OF HEALTH
Vet Pathol. Author manuscript; available in PMC 2008 August 6.
Published in final edited form as: Vet Pathol. 2008 July ; 45(4): 439-442.
Cytochrome b, Expression in Gonadectomy-induced Adrenocortical Neoplasms of the Domestic Ferret (Mustela putorius furo)
S. Wagner, M. Kiupel, R.A. Peterson II, M. Heikinheimo, and D.B. Wilson Departments of Pediatrics and Molecular Biology & Pharmacology, Washington University School of Medicine, St. Louis, MO (SW, MH, DBW); University of Applied Sciences Mannheim, Mannheim, Germany (SW); GlaxoSmithKline, Research Triangle Park, NC (RAP); Department of Pathobiology and Diagnostic Investigation, Michigan State University College of Veterinary Medicine, Lansing, MI (MK); Children’s Hospital, Institute of Biomedicine, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland (MH)
Abstract
Whereas the adrenal glands of healthy ferrets produce only limited amounts of androgenic steroids, adrenocortical neoplasms that arise in neutered ferrets typically secrete androgens or their derivative, estrogen. The 17,20-lyase activity of cytochrome P450 17a-hydroxylase/17,20-lyase (P450c17) must increase to permit androgen biosynthesis in neoplastic adrenal tissue. We screened ferret adrenocortical tumor specimens for expression of cytochrome b5 (cyt b5), an allosteric regulator that selectively enhances the 17,20-lyase activity of P450c17. Cyt b5 immunoreactivity was evident in 24 of 25 (96 %) adrenocortical adenomas/carcinomas from ferrets with signs of ectopic sex steroid production. Normal adrenocortical cells lacked cyt b5, which may account for the low production of adrenal androgens in healthy ferrets. Other markers characteristic of gonadal somatic cells, such as luteinizing hormone receptor, aromatase, and GATA4, were co-expressed with cyt b5 in some of the tumors. We conclude that cyt b5 is upregulated during gonadectomy-induced adrenocortical neoplasia and is a marker of androgen synthetic potential in these tumors.
Keywords
adrenal cortex neoplasms; ferrets; luteinizing hormone receptors; Mustelidae; ovariectomy; orchiectomy; steroidogenesis
The adrenal cortex is a major source of steroid hormones, which are synthesized from cholesterol through the sequential activities of a series of enzymes (Fig. 1). A dual function enzyme, cytochrome P450 17a-hydroxylase/C17-C20 lyase (P450c17), catalyzes both the 17a-hydroxylation reaction required for the production of cortisol and the 17,20-lyase reaction required for the synthesis of the adrenal androgens dehydroepiandrosterone (DHEA) and androstenedione, the precursors of sex steroids. The 17a-hydroxylase and 17,20-lyase activities of P450c17 are differentially regulated; consequently, cortisol production dissociates from adrenal androgen synthesis in certain physiologic and pathophysiologic states. 1-4
One such state is gonadectomy-induced adrenocortical neoplasia in the domestic ferret, Mustela putorius furo. Normally the adrenal glands of intact or neutered ferrets produce cortisol but only minimal amounts of androgenic steroids.6,7 In contrast, adrenocortical neoplasms that arise in gonadectomized ferrets typically secrete androstenedione, DHEA, DHEA-sulfate (DHEA-S) and/or estrogen but little cortisol.5,7 The ectopic production of sex steroids and their progenitors by neoplastic adrenocortical tissue causes a syndrome known as adrenal-associated endocrinopathy (AAE) or hyperadrenocorticism.3,7 Clinical signs of AAE include bilateral symmetrical alopecia, enlargement of the vulva, and squamous metaplasia of prostatic ductular epithelium.3 Adrenocortical neoplasia in neutered ferrets is theorized to be due to chronic stimulation by luteinizing hormone (LH), which in combination with other gonadectomy-induced hormonal changes (e.g., decreased inhibin levels), causes progenitor cells in the adrenal cortex to differentiate into gonadal-like steroidogenic cells.5 Adrenocortical tumors in neutered ferrets express markers characteristic of gonadal somatic cells such as inhibin-a, GATA4, and LH receptor (LHR).5
The 17,20-lyase activity of P450c17 must increase to permit biosynthesis of androgen precursors and sex steroids in gonadectomy-induced adrenocortical neoplasms of ferrets (Fig. 1). We hypothesized that increased intracellular expression of cytochrome b5 (cyt b5), an allosteric regulator that selectively enhances the 17,20-lyase activity of P450c17,2 could account for the preferential production of androgenic steroids by the tumor tissue. To test this hypothesis, we screened archival specimens of adrenocortical tumors from ferrets for expression of cyt b5.
Surgical biopsy and necropsy specimens of ferret adrenocortical neoplasms were obtained from archives of the Michigan State University Animal Health Diagnostic Laboratory (12 cases) and The Ohio State University Department of Veterinary Biosciences (16 cases). Our analysis included cases of anaplastic adrenocortical carcinoma (12), well-differentiated adrenocortical carcinoma (6), adenoma (7), and nodular hyperplasia (3). Criteria for classification of these tumors are listed elsewhere.8 All of these tumors were from gonadectomized ferrets with signs of AAE as documented by review of pathology records. Several of these neoplasms contained residual normal cortex, and some had direct hepatic invasion or metastasis. As negative controls we used autopsy specimens from 5 gonadectomized ferrets with no proliferative lesions in their adrenal glands; none of these ferrets had signs or symptoms of AAE.
Paraffin-embedded tissue sections were processed for immunoperoxidase staining as described previously.8 The following primary antibodies were employed: 1) goat anti-mouse GATA4 IgG (sc-1237, Santa Cruz Biotechnology, Inc., Santa Cruz, CA), 1:200 dilution; 2) mouse anti- human LHR hybridoma conditioned media (CRL-2685, ATCC, Manassas, VA), 1:100 dilution; 3) rabbit anti-human cyt b5 (sc-33174, Santa Cruz Biotechnology, Inc., Santa Cruz, CA), 1:200 dilution; and 4) mouse anti-human inhibin-a (MCA77G, Serotec, Inc., Raleigh, NC), 1:200 dilution. Secondary antibodies used for immunoperoxidase staining were: 1) donkey anti-goat biotinylated IgG (Jackson Immunoresearch, West Grove, PA) 1:200 dilution; 2) donkey anti-mouse biotinylated IgG (Jackson Immunoresearch), 1:200 dilution; and 3) goat anti-rabbit biotinylated IgG (NEF-813, NEN Life Science, Boston MA), 1:200 dilution. The avidin-biotin immunoperoxidase system (Vectastain Elite ABC Kit, Vector Laboratories, Inc., Burlingame, CA) and diaminobenzidine (Sigma-Aldrich Corp., St. Louis, MO) were used to visualize the bound antibody; slides were then counterstained with 100% hematoxylin.
There was a little or no cyt b5 immunoreactivity in normal adrenocortical tissue adjacent to neoplastic lesions (Fig. 2a,b). Nor did we observe cyt b5 expression in adrenal tissue from gonadectomized ferrets without proliferative lesions (data not shown). This lack of cyt b5 may account for the minimal androgen production in the adrenal glands of healthy ferrets. In contrast, cyt b5 immunoreactivity was observed in 96 % of ferret adrenocortical neoplasms
including 17 of 18 carcinomas (Fig. 2b,3a), 7 of 7 adenomas, and 3 of 3 cases of nodular hyperplasia. The cells expressing cyt b5 were large, lipid-laden, and scattered throughout the neoplasms (Fig. 2b,3a). Cyt b5 staining intensity did not differ between malignant and benign adrenocortical lesions. In addition to neoplastic epithelial cells, adrenocortical tumors in ferrets often contain a spindle cell component of uncertain clinical significance.5 Negligible cyt b5 staining was seen in the spindle cell component of the tumors (data not shown). All of the neoplasms exhibiting cyt b5 immunoreactivity were from ferrets with clinical signs of AAE. Thus, cyt b5 is a useful marker of androgen synthetic potential in these neoplasms.
Other markers of gonadal steroidogenic cell differentiation such as GATA4 (Fig. 2c), LHR (Fig. 3b), aromatase (Fig. 3c), and inhibin-a (not shown) were co-expressed with cyt b5 (Fig. 3a) in some of the ferret adrenocortical tumors. Among neoplasms tested for at least four gonadal steroidogenic cell markers, 9 of 9 (100 %) expressed cyt b5, 6 of 9 (67 %) expressed GATA4, 4 of 9 (44 %) expressed LHR, and 4 of 9 (44 %) expressed inhibin-a. Consistent with the notion that P450c17 is essential for cortisol and androgen biosynthesis, P450c17 immunoreactivity was evident in normal zona fasciculata and zona reticularis cells and in 7 of 9 (78 %) adrenocortical neoplasms (Fig. 3d).
In primates, as in ferrets, the expression of cyt b5 in normal and neoplastic adrenocortical tissue correlates the capacity to produce androgens. The onset of cyt b5 expression in the human adrenal cortex coincides with increases in circulating levels of adrenal androgens during adrenarche.1 Similarly, induction of cyt b5 in the adrenal cortex of female marmosets correlates with the capacity to secrete DHEA.9 Elevated levels of cyt b5 have been reported in adrenocortical adenomas from two patients with high circulating androgen levels.4 Conversely, functional human adrenocortical tumors that produce cortisol rather than androgens have been shown to express low levels of cyt b5.4
In theory, other mechanisms besides increased expression of cyt b5 could contribute to the preferential production of sex steroids by neoplastic adrenocortical cells in neutered ferrets. Elevated LH levels stimulate cAMP production in steroidogenic cells, and cAMP-induced phosphorylation of human P450c17 stimulates its 17,20-lyase activity, whereas dephosphorylation abrogates this activity.10 In some humans with adrenocortical neoplasms, high circulating levels of DHEA or DHEA-S have been attributed to reduced 3ß- hydroxysteroid dehydrogenase (3ß-HSD) activity in the tumors (Fig. 1).3 Whether these alternative mechanisms contribute to androgen production in ferret adrenocortical neoplasms awaits further study.
We conclude that cyt b5 is upregulated during gonadectomy-induced adrenocortical neoplasia in ferrets and is a marker of androgen synthetic potential in these tumors. We propose that increased cyt b5 expression accounts in part for the preferential production of adrenal androgens and estrogen by these neoplasms.
Acknowledgements
This work was supported by the NIH (DK075618 and DK52574), the Sigrid Juselius Foundation, and the Academy of Finland.
References
1. Auchus RJ. Overview of dehydroepiandrosterone biosynthesis. Semin Reprod Med 2004;22:281-288. [PubMed: 15635496]
2. Akhtar MK, Kelly SL, Kaderbhai MA. Cytochrome b5 modulation of 17a hydroxylase and 17-20 lyase (CYP17) activities in steroidogenesis. J Endocrinol 2005;187:267-274. [PubMed: 16293774]
3. Sakai Y, Yanase T, Hara T, Takayanagi R, Haji M, Nawata H. Mechanism of abnormal production of adrenal androgens in patients with adrenocortical adenomas and carcinomas. J Clin Endocrinol Metab 1994;78:36-40. [PubMed: 8288710]
4. Sakai Y, Yanase T, Takayanagi R, Nakao R, Nishi Y, Haji M, Nawata H. High expression of cytochrome b5 in adrenocortical adenomas from patients with Cushing’s syndrome associated with high secretion of adrenal androgens. J Clin Endocrinol Metab 1993;76:1286-1290. [PubMed: 8496319]
5. Bielinska M, Kiiveri S, Parviainen H, Mannisto S, Heikinheimo M, Wilson DB. Gonadectomy-induced adrenocortical neoplasia in the domestic ferret (Mustela putorius furo) and laboratory mouse. Vet Pathol 2006;43:97-117. [PubMed: 16537928]
6. Donovan BT, Matson C, Kilpatrick MJ. Effect of exposure to long days on the secretion of oestradiol, oestrone, progesterone, testosterone, androstenedione, cortisol and follicle-stimulating hormone in intact and spayed ferrets. J Endocrinol 1983;99:361-368. [PubMed: 6417256]
7. Rosenthal KL, Peterson ME. Evaluation of plasma androgen and estrogen concentrations in ferrets with hyperadrenocorticism. J Am Vet Med Assoc 1996;209:1097-1102. [PubMed: 8800255]
8. Peterson RA, Kiupel M, Capen CC. Adrenal cortical carcinomas with myxoid differentiation in the domestic ferret (Mustela putorius furo). Vet Pathol 2003;40:136-142. [PubMed: 12637752]
9. Pattison JC, Saltzman W, Abbott DH, Hogan BK, Nguyen AD, Husen B, Einspanier A, Conley AJ, Bird IM. Gender and gonadal status differences in zona reticularis expression in marmoset monkey adrenals: Cytochrome b5 localization with respect to cytochrome P450 17,20-lyase activity. Mol Cell Endocrinol 2007;265-266:93-101. [PubMed: 17222503]
10. Zhang LH, Rodriguez H, Ohno S, Miller WL. Serine phosphorylation of human P450c17 increases 17,20-lyase activity: implications for adrenarche and the polycystic ovary syndrome. Proc Natl Acad Sci U S A 1995;92:10619-10623. [PubMed: 7479852]
Cholesterol
P450scc
Pregnenolone
P450c17
17a-OH Pregnenolone
P450c17
DHEA
3B-HSD
3B-HSD
Cyt b5
3B-HSD
Progesterone®
P450c17
17a-OH Progesterone
P450c17
Androstenedione:
P450c21
P450c21
Cyt b5
17B-HSD
DOC
11-Deoxycortisol
Testosterone
P450c11
P450c11
Aromatase
Corticosterone
Cortisol
Estrogen
P450aldo
1
Aldosterone
Fig. 1. Steroid hormone biosynthesis in normal (solid lines) versus neoplastic (dashed lines) adrenocortical cells. All steroidogenic cells share the capacity to mobilize and cleave cholesterol. The repertoire of enzymes distal to P450scc determines the steroidogenic capacity of a given cell. Note that P450c17 has both 17a-hydroxylase and 17,20-lyase activities. Cyt b5 selectively enhances the 17,20-lyase activity of P450c17 through allosteric effects. Abbreviations: 3ß-HSD, 3ß-hydroxysteroid dehydrogenase; 17ß-HSD, 17ß-hydroxysteroid dehydrogenase; cyt b5, cytochrome b5; DOC, deoxycorticosterone; DHEA, dehydroepiandrosterone; P450aldo, aldosterone synthase; P450c11, cytochrome P450 11ß- hydroxylase; P450c17, cytochrome P450 17a-hydroxylase/17,20-lyase; P450c21, cytochrome P450 21-hydroxylase.
acc
acc
acc
2a
m
2b
m
2c
m
3a
3b
3c
3d